Stock screener

VRTX

Conviction 100HealthcareScan · Mon, Aug 10, 2026
VRTX$523.93+5.62%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
2
2
Vol MA14 1.59M
May 11May 28Jun 16Jul 6Jul 23Aug 10
VERTEX PHARMACEUTICALS INC / MAPHARMACEUTICAL PREPARATIONSwww.vrtx.com
Price523.93
Change+5.62%
Gap+9.42%
Rel volume3.37×
Avg volume1.48M
Avg $ vol722.22M
SMA 20483.02
SMA 50474.68
SMA 200455.17
Price vs 50+10.38%
Price vs 200+15.11%
MA stackbullish
50/200 cross
Supertrendup · 480.30
RSI (14)70
MACD hist2.65
MACD crossbull · 1d
Stoch %K / %D74 / 79
ADX (14)18
+DI / −DI37 / 11
RSI divergence
MACD divergenceBullish
ATR %+3.12%
ADR %2.70%
52w high529.59
52w low366.54
From 52w high-1.07%
Above 52w low+42.94%
New 52w highNo
SqueezeFired
Bollinger width9.20%
%B1.42
Donchian pos73.51%
Donchian high545.17
Donchian low465.00
AVWAP (52w high)529.69
vs AVWAP high-1.09%
AVWAP (52w low)444.65
vs AVWAP low+17.83%
OBV trendUp
Chaikin MF (20)-0.15
Today vs 20d3.37×
Avg vol (14d)1.59M
Avg vol (20d)1.48M
Avg $ vol (20d)722.22M
Market cap
RS 3m (vs SPY)+11.03%
RS 6m (vs SPY)-5.99%
RS line new highNo
Trend template8/8
Technical rank80.1
1 week+11.30%
1 month+7.94%
3 months+21.90%
6 months+9.63%
1 year+39.48%
YTD+15.88%
P/E31.80
P/B6.21
P/S10.48
P/FCF39.36
EPS15.32
Div yield
ROE19.52%
ROA14.42%
Debt/Eq0.01
Current3.19
EV/EBITDA27.31
Gross margin
Net margin32.94%
Rev growth8.90%
EPS growth838.09%
Price target559.27
Target upside12.75%
Analyst ratingBuy
Institutional105.46%
Ent. value119.68B
Revenue3.33B
Net income1.1B
Gross profit
Free cash flow3.19B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out253.81M
Employees6.4K
ListedWed, Jul 31, 1991
Free float
Float %
Short interest
Days to cover
Short volume
Squeeze score
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeA+
Conviction100 / 100
Pattern quality
Tech rank80.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance518.78
Support466.70
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VRTX · 10 recent

All disclosures →
MemberSideAmount
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2024-05-03
Sell$1K–$15K
Alan Armstrong
Alan Armstrong
senate · R · OK · traded 2026-03-27
Buy$1K–$15K
David J. Taylor
David J. Taylor
house · R · OH · traded 2025-08-07
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2024-12-11
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-11
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-10
Sell$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-05-12
Sell$15K–$50K
Byron Donalds
Byron Donalds
house · R · FL · traded 2025-03-20
Sell$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-03-13
Buy$15K–$50K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-02-24
Buy$15K–$50K

Insider activity

SEC Form 4 transactions in VRTX · 2 buys · 8 sells

InsiderSideShares
SACHS BRUCE I
Director · Deferred Stock Units · 2026-07-15
Grant99.941
Garber Alan M
Director · Deferred Stock Units · 2026-07-15
Grant31.56
McKechnie Duncan
EVP, Chief Commercial Officer · Common Stock · 2026-07-02
Sell1.54K
Tatsis Ourania
EVP, Chief Reg. & Quality Off. · Common Stock · 2026-07-02
Sell1.5K
Bozic Carmen
EVP and CMO · Common Stock · 2026-06-26
Sell596
Bozic Carmen
EVP and CMO · Common Stock · 2026-06-15
Sell4.06K
Bozic Carmen
EVP and CMO · Common Stock · 2026-06-05
Sell1.75K
Liu Joy
EVP and Chief Legal Officer · Common Stock · 2026-06-01
Sell828
Bozic Carmen
EVP and CMO · Common Stock · 2026-05-29
Sell1.97K
Bunnage Mark E.
EVP, Chief Scientific Officer · Common Stock · 2026-05-15
Sell33

SEC filings

EDGAR filings in VRTX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.